Related Experiment Video

Updated: Apr 24, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.0K

Critical role of STAT3 in melanoma metastasis through anoikis resistance

Neel M Fofaria1, Sanjay K Srivastava1

  • 1Department of Biomedical Sciences & Cancer Biology Center, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, USA.

Oncotarget
|September 13, 2014
PubMed

Insights

STAT3 signaling promotes melanoma cell survival under anoikis conditions, enhancing their metastatic potential. Inhibiting STAT3 or its signaling pathway effectively reduces melanoma metastasis and tumor formation.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Anoikis, or anchorage-independent cell death, is a crucial barrier to metastasis.
  • Resistance to anoikis is a hallmark of metastatic cancer cells.
  • The role of STAT3 in anoikis resistance in melanoma metastasis requires elucidation.

Purpose of the Study:

  • To investigate the role of Signal Transducer and Activator of Transcription 3 (STAT3) in anoikis resistance in melanoma cells.
  • To determine if STAT3 signaling contributes to the metastatic potential of melanoma.

Main Methods:

  • Melanoma cells were cultured under both anchorage-dependent and -independent conditions.
  • Expression and phosphorylation of STAT3 at Y705 were analyzed.
  • STAT3 inhibitors (AG 490, piplartine) and STAT3 silencing were employed.
  • Over-expression of STAT3 and IL-6 treatment were performed.
  • Cell migration, invasion, anoikis resistance, and tumor formation/metastasis in SCID-NSG mice were assessed.

Main Results:

  • Melanoma cells resistant to anoikis exhibited higher migration and invasion rates.
  • Anoikis-resistant cells showed significantly higher STAT3 expression and phosphorylation at Y705.
  • STAT3 inhibitors induced anoikis in a dose-dependent manner.
  • STAT3 over-expression or IL-6 treatment increased anoikis resistance and protected cells from inhibitor-induced anoikis.
  • STAT3 silencing reduced anoikis resistance and migratory potential.
  • STAT3 knockdown or inhibitor treatment significantly impaired tumor formation and metastasis in vivo.

Conclusions:

  • STAT3 is a critical mediator of anoikis resistance in melanoma cells.
  • STAT3 signaling significantly enhances the metastatic potential of melanoma.
  • Targeting STAT3 represents a promising therapeutic strategy to inhibit melanoma metastasis.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K
Experimental Metastasis Assay08:28

Experimental Metastasis Assay

Published on: August 24, 2010

20.3K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K